| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/24/2000 | WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19907598A1 New DNA encoding plant FK506-binding protein analog useful for producing transgenic plants with altered architecture and for studying immunosuppressants |
| 08/24/2000 | DE19907209A1 Nucleic acid, useful for producing transgenic plants with altered nucleobase transport, encodes a nucleobase transporter protein of Arabidopsis thaliana |
| 08/24/2000 | DE19860834C1 Methode zur zellulären High-Throughput-Detektion von nukleären Rezeptor-Liganden-Interaktionen Method for cellular high-throughput detection of nuclear receptor-ligand interactions |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2371872A1 Methods and compositions for regulating protein-protein interactions |
| 08/24/2000 | CA2371821A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/24/2000 | CA2371799A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | CA2368461A1 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | CA2368309A1 Peptide variants of the tumour marker muc1 and the use thereof |
| 08/24/2000 | CA2364267A1 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | CA2362987A1 Receptor assay |
| 08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | CA2362943A1 Pyk2 binding proteins |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | CA2362300A1 Human lipid-associated proteins |
| 08/24/2000 | CA2362284A1 Modified calycins |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2361273A1 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | CA2359610A1 Malaria vaccine |
| 08/24/2000 | CA2359075A1 An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
| 08/23/2000 | EP1029924A1 Nucleic acids having promoter activity and transgenic plants containing the same |
| 08/23/2000 | EP1029923A1 Method for conveying BNYVV resistance to sugar beet plants |
| 08/23/2000 | EP1029922A2 DNA fragments having basidiomycete-derived promoter activity and their use |
| 08/23/2000 | EP1029921A1 Serpin resistant chymotrpsin superfamily proteases, particularly PAI-1 resistant t-PA, complementary inhibitor mutants; compositions; genes; expressions |
| 08/23/2000 | EP1029918A1 Killer t cell receptor recognizing human immunodeficiency virus |
| 08/23/2000 | EP1029917A1 The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| 08/23/2000 | EP1029916A1 Human lysophosphatidic acid receptor and use thereof |
| 08/23/2000 | EP1029915A2 Expression of G protein coupled receptors in yeast |
| 08/23/2000 | EP1029914A2 Growth hormone-regulated growth marker gene |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029551A2 Nitrogen monoxide metabolite-polyoxyalkylene-hemoglobin complex |
| 08/23/2000 | EP1029550A1 Preventives and remedies for diffuse lung diseases |
| 08/23/2000 | EP1029548A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 08/23/2000 | EP1029547A1 Pharmaceutically active compounds and method for identifying same |
| 08/23/2000 | EP1029546A1 Heparin cofactor ii preparations and process for producing the same |
| 08/23/2000 | EP1029082A2 DETECTION AND TYPING OF THE $i(iceA) GENE OF $i(HELICOBACTER PYLORI) |
| 08/23/2000 | EP1029081A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| 08/23/2000 | EP1029080A1 Human blood bacterium |
| 08/23/2000 | EP1029070A1 Transfecting peptide vector, composition containing same and applications |
| 08/23/2000 | EP1029068A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 08/23/2000 | EP1029066A1 Corn cdna encoding southern leaf blight resistance protein |
| 08/23/2000 | EP1029065A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
| 08/23/2000 | EP1029064A1 Protein production in transgenic alfalfa plants |
| 08/23/2000 | EP1029057A1 Reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
| 08/23/2000 | EP1029056A2 Plant-optimized genes encoding pesticidal toxins |
| 08/23/2000 | EP1029055A2 Essential fungal genes and their use |
| 08/23/2000 | EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/23/2000 | EP1029053A1 Nucleic acid fragments and polypeptide fragments derived from mycobacterium tuberculosis |
| 08/23/2000 | EP1029052A2 Neisserial antigens |
| 08/23/2000 | EP1029051A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 08/23/2000 | EP1029050A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 08/23/2000 | EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 08/23/2000 | EP1029048A2 Sequences for targeting metastatic cells |
| 08/23/2000 | EP1029047A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses |
| 08/23/2000 | EP1029046A2 Wnt-1 inducible genes |
| 08/23/2000 | EP1029045A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 08/23/2000 | EP1029044A1 Tissue cement proteins from rhipicephalus appendiculatus |
| 08/23/2000 | EP1029043A1 Human receptor proteins; related reagents and methods |
| 08/23/2000 | EP1029042A1 A ph sensitive potassium channel in spermatocytes |
| 08/23/2000 | EP1029041A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 08/23/2000 | EP1029039A1 Non-transgenic animal model of alzheimer's disease |
| 08/23/2000 | EP1029038A1 Mammals lacking expression of osteoprotegerin |
| 08/23/2000 | EP1029034A1 Signal peptide containing proteins and uses therefor |
| 08/23/2000 | EP1029033A1 MURD PROTEIN AND GENE OF $i(STREPTOCOCCUS PYOGENES) |
| 08/23/2000 | EP1028980A1 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 08/23/2000 | EP1028977A2 Bifidus stimulating peptides |
| 08/23/2000 | EP1028976A2 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained |
| 08/23/2000 | EP1028975A1 Artemin, a novel neurotrophic factor |
| 08/23/2000 | EP1028974A1 Secreted proteins and polynucleotides encoding them |
| 08/23/2000 | EP1028973A1 IgG-BINDING PROTEIN FROM $i(STAPHYLOCOCCUS) AND NUCLEOTIDE SEQUENCE ENCODING THIS PROTEIN |
| 08/23/2000 | EP1028972A2 MULTI-MER PEPTIDES DERIVED FROM $i(HEPATITIS C VIRUS) ENVELOPE PROTEINS FOR DIAGNOSTIC USE AND VACCINATION PURPOSES |
| 08/23/2000 | EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/23/2000 | EP1028774A1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 08/23/2000 | EP1028747A1 Novel igf-i composition and its use |
| 08/23/2000 | EP1028744A2 Neuronal uses of bmp-11 |
| 08/23/2000 | EP1028742A1 Host derived proteins binding hcv: medical, diagnostic and purification use |
| 08/23/2000 | EP1028741A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/23/2000 | EP1028739A2 Use of protein h as cytostatic agent |
| 08/23/2000 | EP1028735A1 Therapeutic methods comprising use of a neuregulin |
| 08/23/2000 | EP1028715A1 Dosage composition for nasal delivery and method of use of the same |
| 08/23/2000 | EP0866799A4 Apolipoprotein e2 and treatment of alzheimer's disease |
| 08/23/2000 | EP0584247B1 Compositons for the treatment of chronic fatigue syndrome |
| 08/23/2000 | CN1264429A Metastasis models using green fluorescent protein (GFP) as marker |
| 08/23/2000 | CN1264427A Osteoprotegernin binding proteins and receptors |
| 08/23/2000 | CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity |
| 08/23/2000 | CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 08/23/2000 | CN1264424A Isolated nucleic acid melecules encoding SSX family members and uses thereof |
| 08/23/2000 | CN1264390A 胶原凝胶 Collagen gel |
| 08/23/2000 | CN1264389A Hop mosaic virus gene and method for detecting hop mosaic virus |
| 08/23/2000 | CN1263946A Synthetic insecticide crystalline protein gene |
| 08/23/2000 | CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use |
| 08/23/2000 | CN1055726C Reconstituted body vaccine and method for prepn. thereof |
| 08/23/2000 | CN1055725C Gene of factor strenthening coding cell with large nucleus |
| 08/23/2000 | CN1055702C Extraction of cell-bound protein from bordetella |
| 08/23/2000 | CN1055701C Piptide capable of inducing immune response against HIV and edicine for AIDS preventive and remedy containing the peptide |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/22/2000 | US6107548 Nucleotide and amino acid sequences; for transgenic plants with fruit having improved flavor or texture |